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Gene technology on animals has increased enormously in Sweden during 
the 1990s. Most of it has to do with transgenic laboratory animals. 
Before this increase began, there was an official investigation of 
potential ethical problems of animal biotechnology, in which it was said: 
‘We have the possibility to set the limits "from the beginning".’ And it 
also tried to do it. 
 
This investigation was set up in 1989, when the Swedish government 
appointed a Principal Administrative Officer of the Ministry of 
Agriculture to make a so-called one-man investigation about gene 
technology used on animals and plants. A white paper from this 
investigation was published in February 1990 with the title Genteknik – 
växter och djur (Gene technology–plants and animals).1 In the following, 
this white paper is called ‘the first report’. 
 
However, in March 1990, the same government decided to set up a new 
investigation, which was called ‘The Commission on Gene Technology’. 
This was a big, so-called parliamentary commission with several 
politicians and experts in it and led by a retired Vice-Chancellor of a 
prestigious university in Sweden. This commission publicized its white 
paper in September 1992 with the title Genteknik – en utmaning (Gene 
technology–a challenge).2  In the following, this white paper is called 
‘the second report’. 
 
The first investigation was commissioned by the Minister of Agriculture 
and the second by the Minister of Justice.  It is unclear whether there had 
been any contact between the ministers about the issue. The existence of 
the first report is briefly mentioned in the second, but there are no real 
comments on it.  
 
The Commission had a wider objective than the one-man investigation. 
However, the Commission decided in an early stage not to deal with gene 
technology on human beings, with the motivation that this subject had 
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already been treated by an earlier investigation that had published a 
white paper in 1984.  The fact that a white paper on gene technology on 
animals and plants had been published much later, namely ‘the first 
report’, did not prevent the Commission from dealing with the report.  
Whether this is a deliberate shift of policy from the government is 
unclear.  One could easily interpret the creating of the Commission as a 
rejection of the first report, but knowing about the long procedures 
before a Commission is set up I would hardly thing that this is a probable 
explanation.  Rather, the cause seems to have been ignorance about the 
investigation that was already done.  Also, the Principal Administrative 
Officer who made the first investigation was appointed as one of the 
experts on the Commission. 
 
The first report stated several restriction, while the second report was 
rather liberal towards the use of gene technology.  Some examples of 
considerations and suggestions in the first report are these: 
 
–  Gene technology used on animals is discussed mainly from an ethical 
point of view. In contrast, gene technology used on plants and micro 
organisms is discussed from the perspective of potential risks. The 
reason for this distinction of perspectives is that animals have moral 
standing, while plants and micro organisms with these things. have not. 
 
–  Generally, it is said that a Swedish prohibition or moratorium for 
research in gene technology would be both unwise and unrealistic. It 
would affect Sweden very negatively. 
 
–  Animal experiments are examined by ethics committees in Sweden. 
The first report points out that the considerations of these committees are 
limited to aspects concerning the treatment of the animals and the 
question whether the experiment has to be performed on animals. The 
ethics committees do not pay any attention to possible consequences of 
the research, for example if the gene technology research will result in 
products that are not desirable for ethical reasons. The first report says 
that research with gene technology on animals should be reported and 
examined from an ‘extended ethical point of view’. This should be done 
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by a suggested Gene Technology Advisory Board. According to the 
report: 
 
–  Research with gene technology on food-producing animals with the 
goal of increasing the growth or production shall always be disapproved.  
 
–  Research with gene technology on food-producing animals or pets 
shall always be disapproved if a gene from a different species, including 
human beings, is brought into the animal. 
 
–  When animals modified with gene technology are ready to be let out in 
the environment or in production, the advisory ethical decisions will be 
insufficient.  The existing animal ethics committees decide to approve or 
disapprove single applications (or protocols) concerning experiments on 
animals.  However, this decision is only an advice  to the scientist. He 
doesn’t have to follow the decision. He can perform an experiment even 
if the application has been disapproved  What is needed however is a 
binding regulation. 
 
The considerations of the second report are more vague and 
metaphysical. Two questions occur time and again: 
 
(1)  Does nature have an intrinsic value and, if  so, in what sense? 
(2)  Do humans have the right to alter nature and, if so, is there a limit to 
this right? 
 
The second report presents a value basis with the following ingredients: 
 
– The existence of an intrinsic value in nature. 
 
– The Reverence for life principle (taken from Albert Schweitzer, of 
course). 
 
– The doctrine of environmental protection, which means that one should 
‘prevent serious and irreversible disturbances in the fundamental 
functions of natural ecosystems’. 
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– A Kantian view on nonhuman nature, including animals. 
 
– Animal well-being shall be the main basis for the assessment of gene 
technology used on animals. 
 
Some more practical suggestions in the second report were the following: 
 
– It shall be permitted that plants, animals and micro organisms be 
altered for ‘important purposes’. 
 
– It shall be permitted that patents on living matter, including animals, be 
granted. 
 
– It shall be permitted that all kinds of transgenic animals be constructed. 
 
– It shall be permitted that chimeric animals be constructed for research 
purposes. 
 
– No general prohibitions should be included in the law.  
 
Clearly, there is an inconsistency both between the value basis and the 
practical suggestions and internally in the value basis itself. The first 
report draws a line between animals on one side and nature in general on 
the other. In this report, animals are regarded as individuals. In contrast, 
the second report is more ‘holistic’ and regards nature as a whole. The 
second report does not make any distinction between animals and other 
natural objects as potential possessors of moral standing. This confusion 
entails that the suggestions of this report are either vague or inconsistent 
with some items in the chosen value basis. There are also details in some 
statements of the experts in the Commission that simply clash with 
suggestions in the first report. One example is when the theological 
expert of the Commission says that he can see no ethical problems in 
connection with transferring human genes into animals used for food. 
 
One can ask how it can be that two official investigations, set up by the 
same Swedish government, within the period of a couple of years could 
reach such deviating conclusions. And one can ask why this fact has not 
 61 
been regarded and discussed. Why was the first report suddenly 
forgotten, as soon as the Commission had been set up? Why did the 
different ministers of the government and their staff not communicate 
with each other – there are no signs of such a communication? 
 
I have no definite answers to these questions, but there are some possible 
explanations: The commitment of the persons involved varied and was 
also different in direction. The Minister of Agriculture was the one who 
had forced through the bill of the internationally well-known animal 
protection law in 1988. The Principal Administrative Officer, who made 
the first investigation, was a close staff member who had done much of 
the preparatory work for this law.The Ministry of Justice had no 
commitment to animal welfare. They probably regarded it necessary to 
set up a commission for harmonizing the Swedish law on gene 
technology with the European Union, in which Sweden some years later 
became a member state. 
 
The first report is not hostile to science, but it draws some limits for the 
treatment of animals in the gene technology context. The second report 
gives power to the scientific community to form their own practices. The 
practical and legal consequences in the Swedish society have been more 
in accordance with the second report than with the first one. However, 
there were some parliamentary decisions made that from the beginning 
upset the scientific community. One of these decisions was the forming 
of a new agency for gene technology, which in fact only constituted  a 
reorganization of an agency that had been existing since 1980. Also, the 
lamentations from scientists soon abated. 
 
One cannot say that there is any difference in the treatment of animal 
ethics in Sweden as a consequence of the first or the second report. 
However, the quantity of experiments with animals modified by gene 
technology has increased considerably.3 
 
 
 
Notes 
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